Skip to main content
Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.19
-0.01 (-0.16%)
Apr 29, 2026, 10:09 AM EDT - Market open

Candel Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
55
Market Cap
453.40M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022125.00K--
Dec 31, 2021125.00K--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Valneva SE 205.07M
REGENXBIO 170.44M
Ginkgo Bioworks Holdings 170.16M
4D Molecular Therapeutics 85.21M
ADC Therapeutics 81.36M
Entrada Therapeutics 25.42M
Prelude Therapeutics 12.14M
Armata Pharmaceuticals 4.90M
Revenue Rankings

CADL News

More News